Brijesh Roy
Investment Manager @ Mercia Asset Management
Oxford, United Kingdom
Brijesh Roy is a seed investor at Mercia Asset Management in Oxford focused on Health Care and Medical Device. Brijesh is an Investment Manager with a focus on university spinouts across the Midlands region.Prior to joining Mercia, Brijesh worked at Isis Innovation Ltd as a Technology Transfer Manager, managing a diverse portfolio of early stage biotech. medtech and software technologies from Oxford University. Over five years, he filed numerouspatents, negotiated dozens of intellectual property licensing deals and also raised £12m to create gene therapy company Nightstarx Ltd, the largest venture capital investment ever made to a new university spinout in Europe at that time.Brijesh also worked as an Associate Strategy Consultant at L.E.K Consulting and interned as a Healthcare Analyst at hedge fund Millennium Partners.He holds a Ph.D in Biochemistry from University College London, and an MBiochem in Molecular and Cellular Biochemistry from the University of Oxford. He has also co-authored numerous academic papers within the field of Biochemistry.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Brijesh Roy invests in
Stages Brijesh Roy invests in
Countries Brijesh Roy invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Medical Device 2 (67%)
- Software 1 (33%)
- Wellness 1 (33%)
- Health Diagnostics 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Koalaa
|
Koalaa offers comfy, soft prosthetic arms and personalized support, for babies, kids, and adults. Koalaa's mission is to make prostheses comfortable and affordable to anyone on the planet. | $1.2M / Seed / Feb 15, 2024 | |
SERG Technologies
|
SERG Technologies is re-defining the way we interact with technology by creating reliable and functional wearables that can be used for activity tracking, monitoring health and fitness, and gesture recognition for smart devices.Our unique sensors detect tiny, subconscious movements that indicate a wearer’s intent, we turn these into controlsignals for everything from TV’s to smart prosthetics, resulting in almost instant response times. We are also developing new tools to allow Parkinson's patients to track their symptoms, providing vital new information to their doctors, leading to long term improvements to the efficacy their treatment.SERG was founded to make the gesture control of technology accessible for everyone and easier to use than ever before. | $1.9M / Seed / Jul 12, 2022 | |
Gripable
|
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients.GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. Thisis the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home. | $2.2M / Seed / Mar 24, 2021 |
Co-Investors
About Mercia Asset Management
Mercia Asset Management invest across four distinct asset classes of venture, private equity and debt, referred to as our ‘Complete Capital Solution.Mercia Asset Management ision is to be the first choice for investors, investees and employees and, by aspiring to be the first choice, we believe that Mercia will deliver superior returns for businessowners, shareholders and fund investors alike.
Mercia Asset Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Aaron Lawson-Clark
Investment Director
|
|||
Ashwin Kumaraswamy
Investment Director
|
|||
|
Brijesh Roy
Investment Manager
|
|||
Clive Downward
Investment Director
|
|||
Graham Davies
Investment Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Brijesh Roy invest in?
Brijesh Roy invests primarily in Health Care, Medical Device and Software startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Brijesh Roy last invest?
The most recent investment recorded for Brijesh Roy closed in Feb 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
